Terry Moody

Dr. Terry Moody


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2011 in Current Opinion in Endocrinology, Diabetes and Obesity
Verified
Journal Article
Closed access
TMTerry Moody
Terry Moody
TITetsuhide Ito
Tetsuhide Ito
NONuramy Osefo
Nuramy Osefo
RJRobert T Jensen
Robert T Jensen
Purpose of review Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as well as the three classes of G-protein-coupled receptors mediating their effects, are widely distributed in the central nervous system (CNS) and peripheral tissues. These peptides are reported to have many effects in different tissues, which are physiological or pharmacological, and which receptor mediates which effect, has been difficult to determine, primarily due to lack of potent, stable, selective agonists/antagonists. Recently the use of animals with targeted knockout of the peptide or a specific receptor has provided important insights into their role in normal physiology and disease states. Recent findings During the review period, considerable progress and insights has occurred in the understanding of the role of VIP/PACAP as well as their receptors in a number of different disorders/areas. Particularly, insights into their roles in energy metabolism, glucose regulation, various gastrointestinal processes including gastrointestinal inflammatory conditions and motility and their role in the CNS as well as CNS diseases has greatly expanded. Summary PACAP/VIP as well as their three classes of receptors are important in many physiological/pathophysiological processes, some of which are identified in these studies using knockout animals. These studies may lead to new novel treatment approaches. Particularly important are their roles in glucose metabolism and on islets leading to possible novel approaches in diabetes; their novel anti-inflammatory, cytoprotective effects, their CNS neuroprotective effects, and their possible roles in diseases such as schizophrenia and chronic depression.

1 January 1998 in Experimental Lung Research
Verified
Journal Article
Closed access
PDF file
TMTerry Moody
Terry Moody
JLJ. Leyton
J. Leyton
Alfredo MartínezAlfredo Martínez
Alfredo Martínez
SHS. Hong
S. Hong
AMA. Malkinson
A. Malkinson
JMJ. L. Mulshine
J. L. Mulshine
The effects of lipoxygenase inhibitors were investigated using human lung cancer cell lines and A/J mice. By RT-PCR, 5-, 12-, and 15-lipoxygenase mRNA was detected in NSCLC cells. NDGA inhibited 5-LO activity in adenocarcinoma cell line NCI-H1264. Using an MTT assay, NDGA, MK591 and AA861 inhibited the growth of NSCLC cell lines tested with IC50 values of 3, 2, and 7 μM, respectively. Using a clonogenic assay, 10 μM NDGA significantly reduced NSCLC colony number. NDGA significantly slowed NSCLC xenograft growth in nude mice. When the tumors were excised and analyzed, nude mice treated with NDGA had significantly more apoptotic figures than did untreated tumors. A/J mice treated with urethane developed adenomas after 4 months and NDGA administration significantly reduced lung adenoma number. These data indicate that lipoxygenase inhibitors inhibit lung cancer growth and prevent lung carcinogenesis.

1 January 2001 in Peptides
Verified
Journal Article
Closed access
TMTerry Moody
Terry Moody
JCJessica Chiles
Jessica Chiles
MCMarchessini Casibang
Marchessini Casibang
EMElizabeth Moody
Elizabeth Moody
DCDaniel Chan
Daniel Chan
TDThomas Davis
Thomas Davis

1 July 2001 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
TMTerry Moody
Terry Moody
JLJulius Leyton
Julius Leyton
DCDaniel Chan
Daniel Chan
DBDouglas C. Brenneman
Douglas C. Brenneman
MFMati Fridkin
Mati Fridkin
IGIllana Gozes
Illana Gozes

1 January 1998 in Peptides
Verified
Journal Article
Closed access
TMTerry Moody
Terry Moody
JLJulius Leyton
Julius Leyton
EUEdward Unsworth
Edward Unsworth
CJChristy John
Christy John
LLLixin Lang
Lixin Lang
WEWilliam C Eckelman
William C Eckelman

1 January 2001 in European Journal of Pharmacology
Verified
Journal Article
Closed access
Horst Christian WeberHorst Christian Weber
Horst Christian Weber
JWJames Walters
James Walters
JLJulius Leyton
Julius Leyton
MCMarchessini Casibang
Marchessini Casibang
SPSally Purdom
Sally Purdom
TMTerry Moody
Terry Moody